Search Within

Bob Tingkan Li

  1. "2025"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (1)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (7)
  2. Solid Tumor Oncology Division (7)
  3. Thoracic Oncology (7)
  4. Graduate Medical Education (3)
  5. CTCR Scholars (2)
  6. Epidemiology and Biostatistics (2)

More Groups

People
  1. Daniel Gomez (2)
  2. Emily Lebow (2)
  3. Jordan Eichholz (2)
  4. Leah Kratochvil (2)
  5. Lillian Boe (2)
  6. Ahmet Ilica (1)

More People

Years
  1. 2025 (7)
Publications
  1. Advances in Radiation Oncology (1)
  2. Cancer (1)
  3. Cancer Research Communications (1)
  4. International Journal of Radiation Oncology, Biology, Physics (1)
  5. Journal of Clinical Oncology (1)
  6. Nature Medicine (1)

More Publications

Publishers
  1. Elsevier Inc. (2)
  2. American Association for Cancer Research (1)
  3. American Society of Clinical Oncology (1)
  4. Nature Publishing Group (1)
  5. Oxford University Press (1)
  6. Wiley Blackwell (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular determinants of sotorasib clinical efficacy in KRAS(G12C)-mutated non-small-cell lung cancer
    Journal Article

    Skoulidis, F.; Li, B. T.; de Langen, A. J.; Hong, D. S.; Lena, H.; Wolf, J.; Dy, G. K.; Curioni Fontecedro, A.; Tomasini, P.; Velcheti, V.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Intracranial disease control and survival among patients with KRAS-mutant lung adenocarcinoma and brain metastases treated with stereotactic radiosurgery
    Journal Article

    Gaeta, B.; Eichholz, J. E.; Walch, H.; Ilica, A. T.; Boe, L.; Kratochvil, L.; Yu, Y.; Gomez, D. R.; Imber, B. S.; Li, B. T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save
  • Diverse ERBB2/ERBB3 activating alterations and coalterations have implications for HER2/3-targeted therapies across solid tumors
    Journal Article

    Liu, D.; Jee, J.; Drilon, A.; Heilmann, A. M.; Allen, J. M.; Schrock, A. B.; Keller-Evans, R. B.; Li, B. T.
    Cancer Research Communications (2025)

    Fulltext@MSK | Save
  • Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies
    Review

    Reinhorn, D.; Moskovitz, M.; Tap, W. D.; Li, B. T.
    Cancer (2025)

    Fulltext@MSK | Save
  • Cell-free circulating tumor DNA for noninvasive molecular profiling among patients undergoing definitive chemoradiation for locally advanced lung cancer
    Research Letter

    Lebow, E. S.; Eichholz, J.; Boe, L.; Zhang, Z.; Kratochvil, L. B.; Gelblum, D. Y.; Simone, C. B. 2nd; Shepherd, A. F.; Iyengar, P.; Shin, J. Y.; more...
    Advances in Radiation Oncology (2025)

    Fulltext@MSK | Save
  • Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer
    Journal Article

    Skoulidis, F.; Li, B. T.; Hochmair, M.; Govindan, R.; Vincent, M.; van der Wekken, A. J.; Aransay, N. R.; O’Byrne, K. J.; Girard, N.; Griesinger, F.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Preliminary safety, antitumor activity, and circulating tumor DNA (ctDNA) changes with RMC-9805, an oral, RAS(ON) G12D-selective tri-complex inhibitor in patients with KRAS G12D pancreatic ductal adenocarcinoma (PDAC) from a phase 1 study in advanced solid tumors
    Meeting Abstract

    Spira, A. I.; Papadopoulos, K. P.; Kim, D. W.; Parikh, A. R.; Barve, M. A.; Powderly, J. D. 2nd; Starodub, A.; Strickler, J. H.; Li, B. T.; Oberstein, P. E.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save